News
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. LONDON (AP) — The ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which ...
Health and Me on MSN1h
EU Approves 'Twice Yearly' Injectable HIV Drug To Fight The Virus And Stop Transmission
The EU has approved an injectable HIV drug offering a two-month dosage schedule, marking a breakthrough in treatment ...
The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.
Gilead receives positive CHMP opinions under accelerated review from EMA for twice-yearly lenacapavir for HIV prevention: Foster City, California Saturday, July 26, 2025, 13:00 Hr ...
EMA committee recommends marketing approval of Pfizer & BioNTech’s LP.8.1-adapted Covid-19 vaccine: New York Saturday, July 26, 2025, 10:00 Hrs [IST] Pfizer Inc. and BioNTech SE ...
TipRanks on MSN13h
Europe Grants Limited Approval to Eli Lilly’s (LLY) Alzheimer’s Drug
The European Medicines Agency (EMA) has granted limited approval to Eli Lilly’s (LLY) new Alzheimer’s drug Kisunla, reversing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback